Physician profile
Sergio Gonzalez
NPI 1922661594
$581.96
in general payments reported to CMS, 2019-2025
9 companies · $304 in 2025
The $304 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $50.82 · 2022: $110 · 2023: $117 · 2025: $304.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $421.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $420.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $198.46 | 2022-2025 | Ozempic |
| Abbott Laboratories | $100.78 | 2023 | Freestyle Libre 3 |
| Lilly USA, LLC | $97.29 | 2025 | Zepbound |
| Amgen INC. | $81.36 | 2025 | Repatha |
| Boston Scientific Corporation | $37.02 | 2022 | |
| Janssen Pharmaceuticals, INC | $21.59 | 2021 | |
| Smith+Nephew, INC. | $16.23 | 2023 | Pico 14, Pico 7, Renasys Touch |
| Irhythm Technologies, INC. | $15.06 | 2021 | |
| Cardiovascular Systems INC. | $14.17 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sergio Gonzalez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.